Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
14.07
-0.25 (-1.75%)
At close: Sep 11, 2026, 4:00 PM EDT
13.87
-0.20 (-1.42%)
After-hours: Sep 11, 2026, 7:39 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
1,2002,0441,3161,0214582772854263252293532832383383843683804496509501,003
Market Cap Growth (YoY)
304.92%636.96%361.19%139.48%40.70%21.32%-19.26%50.74%36.73%-32.40%-7.84%-23.21%-37.42%-24.68%-41.00%-61.22%-62.11%-55.53%---
Enterprise Value
6171,417978670208-7-442281078116715182153168142135139304583646
Last Close Price
14.0724.2016.4515.687.414.514.646.945.303.747.055.654.796.857.797.618.179.6714.0220.4222.28

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
----21.8511.4846.39--------------
PS Ratio
41.7971.1730.648.262.521.561.795.6421.7239.71332.22----------
PB Ratio
2.464.202.524.381.861.031.041.911.581.022.321.581.291.581.571.361.311.492.002.732.72
P/TBV Ratio
2.464.202.524.381.861.031.041.911.581.022.321.581.291.581.571.361.311.492.002.732.72
P/FCF Ratio
----3.1611.639.3611.22-------------
P/OCF Ratio
----3.0710.018.2310.15-------------

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
21.4949.3422.785.421.15--3.017.1714.06157.06----------
EV/EBITDA Ratio
----12.36----------------
EV/EBIT Ratio
----24.46----------------
EV/FCF Ratio
----1.44--6.00-------------

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.080.080.080.170.160.150.150.190.210.200.300.260.250.220.190.170.160.160.02--
Debt / EBITDA Ratio
----1.531.262.53--------------
Debt / FCF Ratio
----0.281.721.371.12-------------
Net Debt / Equity Ratio
-1.20-1.20-1.20-1.45-1.43-0.93-1.03-1.48-0.97-0.97-0.97-1.04-0.72-0.73-0.76-0.79-0.78-0.81-0.95-1.00-0.99
Net Debt / EBITDA Ratio
3.363.364.487.37-20.85-10.71-46.274.511.641.651.081.360.991.221.571.992.222.673.734.896.13
Net Debt / FCF Ratio
18.1818.1831.9112.29-2.42-10.46-9.32-8.673.163.222.122.971.081.331.702.052.482.763.785.015.96
Asset Turnover
0.060.060.080.280.470.510.480.200.050.020.00----------
Quick Ratio
10.4910.499.446.056.457.005.532.375.836.424.695.007.9110.7011.4010.5813.3019.9125.3920.8028.80
Current Ratio
10.5810.589.546.126.547.165.612.406.036.564.825.078.0910.9011.7310.7913.5520.1125.6520.9629.08
Return on Equity (ROE)
-42.66%-42.66%-32.62%-16.94%9.28%9.81%2.88%-36.15%-61.23%-59.51%-68.28%-60.07%-55.88%-48.60%-40.94%-35.06%-30.64%-28.44%-34.49%-40.35%-
Return on Assets (ROA)
-21.63%-21.63%-16.41%-7.64%1.37%2.66%-0.40%-13.66%-28.43%-27.99%-31.26%-27.72%-28.89%-25.70%-23.35%-19.82%-17.41%-16.14%-20.34%-21.92%-
Return on Invested Capital (ROIC)
-----265.90%---1870.48%-2397.39%--632.43%-256.09%-228.59%-215.11%-187.01%-170.34%-262.01%-999.94%-3923.66%-6504.08%
Return on Capital Employed (ROCE)
-28.80%-28.80%-22.30%-14.10%2.10%4.70%-0.60%-28.80%-47.20%-46.20%-63.90%-55.70%-61.40%-51.00%-42.40%-35.50%-30.80%-27.10%-25.70%-20.80%-16.50%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
-13.42%-7.88%-9.88%-3.78%4.58%8.71%2.16%-17.05%-36.71%-57.03%-38.27%-47.85%-55.86%-37.05%-30.40%-29.46%-26.61%-20.86%-13.17%-7.79%-7.00%
FCF Yield
-2.67%-1.57%-1.49%-2.69%31.69%8.60%10.68%8.91%-19.30%-29.63%-19.75%-22.22%-51.30%-34.78%-28.38%-28.61%-24.04%-19.80%-12.64%-7.28%-6.14%
Buyback Yield / Dilution
-11.90%-11.91%-9.92%-12.39%-22.34%-38.55%-47.16%-43.80%-36.96%-22.51%-12.91%-8.83%-5.76%-4.27%-32.28%-88.91%-240.15%-1769.46%-2177.87%-1548.09%-869.12%
SEC Filings: 10-K · 10-Q